Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CSL is a leading global biotechnology company that develops and delivers innovative biotherapies and influenza vaccines to patients in more than 100 countries. The company operates through three primary business units: CSL Behring, which focuses on rare and serious diseases; CSL Seqirus, one of the world's largest influenza vaccine providers; and CSL Vifor, a leader in iron deficiency and nephrology. CSL's extensive portfolio includes treatments for hemophilia, primary immune deficiencies, and hereditary angioedema, as well as the first-ever gene therapy for hemophilia B. Headquartered in Melbourne, Australia, CSL maintains a significant global footprint with major R&D and manufacturing facilities in the United States, Switzerland, Germany, and the United Kingdom.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CSL Recruitment.